Lab Automation Market worth $9.01 billion by 2030
The report "Lab Automation Market by Product (Robotic Arm, Microplate Reader, Workstation, LIMS, ELN), Application (ADME, Drug Discovery, Diagnostic, Genomic, Proteomic, High Throughput), End User (Pharma, Diagnolab, Forensic, Environmental) - Global Forecast to 2030", is projected to grow from USD 6.36 billion in 2025 to USD 9.01 billion by 2030, which represents a CAGR of 7.2%. The increasing use of high-throughput screening, especially in drug discovery and diagnostic testing, is a significant driver of growth in this field. Automated systems enhance accuracy and reduce the risk of human error, making them ideal for both research laboratories and clinical settings. Advances in robotics, artificial intelligence, and digital data integration are further enhancing automation capabilities to unprecedented levels. Additionally, the rising research & development budgets within the pharmaceutical industry aim to shorten drug development timelines, leading to a greater reliance on automated workflows. The trend toward personalized medicine is also increasing the demand for rapid and precise diagnostic testing. Moreover, government investments in healthcare and infrastructure improvements in emerging markets are expected to support further market growth.
Browse 400 market data Tables and 58 Figures spread through 405 Pages and in-depth TOC on "Lab Automation Market by Product (Robotic Arm, Microplate Reader, Workstation, LIMS, ELN), Application (ADME, Drug Discovery, Diagnostic, Genomic, Proteomic, High Throughput), End User (Pharma, Diagnolab, Forensic, Environmental) - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/lab-automation-market-1158.html
Drug Discovery Dominates Market Share in 2025
The largest segment of the lab automation market in 2025 will be dedicated to drug discovery applications. The development of new drugs involves complex and time-consuming processes that can be significantly enhanced through automation. Automation technologies streamline critical phases such as compound testing and high-throughput screening, improving efficiency in identifying potential drug candidates. These technologies also help reduce labor costs and expedite the drug development process. Notable companies like Agilent Technologies (US), PerkinElmer (US), Tecan Group (Switzerland), and Beckman Coulter (US) offer specialized solutions that facilitate low-risk automated assay setups. The increasing demand for innovative therapeutics in areas such as oncology, neurology, and infectious diseases will further drive the need for automation in drug discovery.
Software Segment to Register Significant Growth Rate over Forecast Period
The automation laboratory market is experiencing a growing demand for solutions that ensure data traceability and integrity. As laboratories aim to increase efficiency, there is a noticeable trend toward acquiring software solutions that can manage and secure large volumes of data. Key areas of focus include systems such as laboratory information management systems (LIMS), electronic laboratory notebooks (ELNs), laboratory execution systems (LES), and scientific data management systems (SDMS).
LIMS are gaining popularity as laboratories require the ability to handle large datasets with greater speed and accuracy. The use of ELNs is also on the rise due to an increasing need for regulatory compliance, enhanced intellectual property protection, and improved management of laboratory instruments. LES systems are facilitating paperless operations, boosting operational efficiency, and reducing administrative burdens. Furthermore, SDMS are becoming essential as laboratories need more advanced tools to record, store, and process complex data in real time.
As laboratories continue to streamline processes and enhance productivity, these software solutions are expected to drive growth in the lab automation industry. The focus on improving data management capabilities is not only promoting operational efficiency but also fostering innovation throughout the sector.
Hospitals & Diagnostic Laboratories Command Market in 2025
The hospitals & diagnostic laboratory segment is expected to capture the largest share of the lab automation market by 2025. The rise in chronic diseases, outbreaks of infectious diseases, and the demand for faster diagnostic results have all contributed to the need for automating these laboratories. Automation improves efficiency by reducing processing times, minimizing errors, and enhancing overall accuracy.
Key technologies in this field include sample handling systems, liquid processing automation, and data management systems. These technologies enable laboratories to conduct multiple tests simultaneously without compromising quality. As automation becomes more integrated into hospitals and diagnostic labs, productivity continues to rise while turnaround times decrease, driving further growth in the lab automation market.
US to Hold Largest Share in North America during Forecast Period
The US is expected to lead the North American lab automation market during the forecast period. This growth is driven by its well-established healthcare infrastructure, a strong presence in the pharmaceutical and biotech industries, and significant investments in research and development for automation technologies. Increasing diagnostic workloads and expanding drug development pipelines are creating a demand for efficient and error-free laboratory processes. Additionally, government initiatives promoting the adoption of artificial intelligence, robotics, and digital systems are boosting market growth. The rapid pace of technology adoption in the country, along with efforts to improve laboratory efficiency and data quality, further reinforces its dominant position in the market.
Major players in this area include:
Siemens Healthineers (Germany), Tecan Group (Switzerland), Thermo Fisher Scientific (US), Waters Corporation (US), Abbott Laboratories (US), Agilent Technologies (US), Becton, Dickinson and Company (US), Biomérieux (France), Danaher Corporation (US), Eppendorf AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland)
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Lab Automation Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
